ESMO recommendations for the application of hematopoietic growth factors.

Richard Greil; L M Jost

doi:10.1093/annonc/mdi813

ESMO recommendations for the application of hematopoietic growth factors.

Richard Greil, L M Jost

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	i80-i82
Journal	ANNALS OF ONCOLOGY
Volume	16 Suppl 1
DOIs	https://doi.org/10.1093/annonc/mdi813
Publication status	Published - 2005

Keywords

SINGLE-ADMINISTRATION PEGFILGRASTIM
DAILY FILGRASTIM
DOUBLE-BLIND
CHEMOTHERAPY
MULTICENTER
CANCER
RISK

Access to Document

10.1093/annonc/mdi813

Cite this

Greil, R., & Jost, L. M. (2005). ESMO recommendations for the application of hematopoietic growth factors. ANNALS OF ONCOLOGY , 16 Suppl 1, i80-i82. https://doi.org/10.1093/annonc/mdi813

Greil, Richard ; Jost, L M. / ESMO recommendations for the application of hematopoietic growth factors. In: ANNALS OF ONCOLOGY 2005 ; Vol. 16 Suppl 1. pp. i80-i82.

@article{8e47f874105a4eed84c2a27d2a024ba5,

title = "ESMO recommendations for the application of hematopoietic growth factors.",

keywords = "SINGLE-ADMINISTRATION PEGFILGRASTIM, DAILY FILGRASTIM, DOUBLE-BLIND, CHEMOTHERAPY, MULTICENTER, CANCER, RISK",

author = "Richard Greil and Jost, \{L M\}",

year = "2005",

doi = "10.1093/annonc/mdi813",

language = "English",

volume = "16 Suppl 1",

pages = "i80--i82",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

}

Greil, R & Jost, LM 2005, 'ESMO recommendations for the application of hematopoietic growth factors.', ANNALS OF ONCOLOGY , vol. 16 Suppl 1, pp. i80-i82. https://doi.org/10.1093/annonc/mdi813

ESMO recommendations for the application of hematopoietic growth factors. / Greil, Richard; Jost, L M.
In: ANNALS OF ONCOLOGY , Vol. 16 Suppl 1, 2005, p. i80-i82.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - ESMO recommendations for the application of hematopoietic growth factors.

AU - Greil, Richard

AU - Jost, L M

PY - 2005

Y1 - 2005

KW - SINGLE-ADMINISTRATION PEGFILGRASTIM

KW - DAILY FILGRASTIM

KW - DOUBLE-BLIND

KW - CHEMOTHERAPY

KW - MULTICENTER

KW - CANCER

KW - RISK

U2 - 10.1093/annonc/mdi813

DO - 10.1093/annonc/mdi813

M3 - Original Article

C2 - 15888768

SN - 0923-7534

VL - 16 Suppl 1

SP - i80-i82

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

ER -

Greil R, Jost LM. ESMO recommendations for the application of hematopoietic growth factors. ANNALS OF ONCOLOGY . 2005;16 Suppl 1:i80-i82. doi: 10.1093/annonc/mdi813